Perinatal management of a preterm neonate affected by hyperprostaglandin E2 syndrome (HPS)

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Acta paediatrica

• Publication date

  2005-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/08035250510043897PMID 16303714
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Salt handling in the distal nephron: lessons learned from inherited human disorders.

  2005cited by this paper
• Induction of Microsomal Prostaglandin E2 Synthase in the Macula Densa in Children with Hypokalemic Salt-Losing Tubulopathies

  2004cited by this paper
• Renal cyclooxygenase-2 (COX-2). Physiological, pathophysiological, and clinical implications.

  2004cited by this paper
• Renal Cyclooxygenase-2 (Cox-2)

  2004cited by this paper
• Pseudo-Bartter syndrome in a neonate on prostaglandin infusion

  2003cited by this paper
• Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies.

  2002cited by this paper
• Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome.

  2002cited by this paper
• Serum pancreatic enzymes define the pancreatic phenotype in patients with Shwachman-Diamond syndrome.

  2002cited by this paper
• Cyclooxygenase 2 and the kidney

  2001cited by this paper
• The renal hemodynamic effects of Aspirin in newborn and young adult rabbits

  2001cited by this paper
• How can one apply rescue indomethacin therapy to a 1-month-old baby with antenatal Bartter syndrome in the case of severe vomiting?

  2001cited by this paper
• Prostaglandin E receptors and the kidney.

  2000cited by this paper
• Schwachman-diamond syndrome: A case report

  2000cited by this paper
• Prenatal and postnatal management of hyperprostaglandin E syndrome after genetic diagnosis from amniocytes.

  1999cited by this paper
• Novel molecular variants of the Na-K-2Cl cotransporter gene are responsible for antenatal Bartter syndrome.

  1998cited by this paper
• Cyclooxygenase-2 in rat nephron development.

  1997cited by this paper
• Cyclooxygenase-2 in rat nephron development.

  1997cited by this paper
• Bartter syndrome and its neonatal variant

  1997cited by this paper
• Shwachman syndrome: exocrine pancreatic dysfunction and variable phenotypic expression.

  1996cited by this paper
• Reference intervals and developmental changes in urinary prostanoid excretion in healthy newborns, infants and children

  1992cited by this paper
• The increased echogenicity of the pancreas in infants and children: the white pancreas

  1987cited by this paper
• Pancreatic lipomatosis in the Shwachman-Diamond syndrome

  1985cited by this paper
• Congenital hypokalemia with hypercalciuria in preterm infants: a hyperprostaglandinuric tubular syndrome different from Bartter syndrome.

  1985cited by this paper

• Pathophysiology and clinical presentations of salt-losing tubulopathies

  2016cites this paper
• Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects

  2011cites this paper
• Primary Molecular Disorders and Secondary Biological Adaptations in Bartter Syndrome

  2011cites this paper
• Loop Disorders: Insights Derived from Defined Genotypes

  2010cites this paper
• A higher level of prostaglandin E2 in the urinary bladder in young boys and boys with lower urinary tract obstruction.

  2009cites this paper
• An improved terminology and classification of Bartter-like syndromes

  2008cites this paper
• Hyperprostaglandin E syndrome: use of indomethacin and steroid, and death due to necrotizing enterocolitis and sepsis.

  2008cites this paper
• The clinical manifestations, the short- and long-term outcomes of Bartter syndrome

  2007cites this paper
• Urinary prostaglandin E2 in the newborn and infant.

  2007cites this paper